On of VEGF164 in vivo is demonstrated by RT-PCR. Final results from three mice bearing flank tumors are shown. In each mouse, the left RNA sample is from the tumor generated with GFP-transfected, whereas the correct sample is from the contralateral tumor generated with VEGF/GFP-transfected tumor. The rightmost lane represents RNA from cultured VEGF/GFP-transfected ID8 cells (optimistic control). VEGF isoforms 188, 164, and 120 were amplified with isoform-specific primers. Only VEGF164 is overexpressed in vivo. -actin RNA documents equal cIAP-1 Antagonist Synonyms quantity of RNA utilised for all samples. G: Real-time quantitative RT-PCR confirms stable overexpression of total VEGF mRNA in vivo. Tumors formed by VEGF/GFPtransfected cells (VEGF) show fourfold higher total VEGF mRNA levels in comparison with contralateral control tumors formed by GFP-transfected cells (manage). Data were normalized with all the housekeeping gene GAPDH.stereomicroscope. Prominent vessels have been readily observed in VEGF-overexpressing tumors (Figure three, B and D). Notably, inside the intraperitoneal model, early metastatic tumors, which had been quite hard to identify grossly or below regular light stereomicroscope as a result of their significantly compact size and random distribution, may be readily detected under epifluorescence owing to GFPSummary of VEGF Protein Expression Levels by Enzyme-Linked Immunosorbent Assay GFP VEGF/GFP hour) 408 45 pg/(106 cells 135 26 (pg/ml) 3172 230 (pg/ml) 112 36 (pg/mg) hour)Conditioned medium Serum Ascites Strong tumor34 16 pg/(10 cells 52 6 (pg/ml) 245 58 (pg/ml) four three (pg/mg)2302 Zhang et al AJP December 2002, Vol. 161, No.Figure 3. GFP expression is steady in vivo and delivers a sensitive tool to monitor tumor growth and metastasis. Stable expression of enhanced GFP in vivo permits for speedy identification of tumors in each flank and intraperitoneal models. A : Flank tumors resected from both sides of your exact same mouse. The borders in between the tumor and standard tissue might be conveniently observed owing towards the distribution of GFP fluorescence. In addition, the nonluminous tumor-associated blood vessels are clearly observed against the fluorescence from the GFP-expressing tumors beneath the fluorescent stereomicroscope. In handle tumors from GFP-transfected ID8 cells (A and B), handful of blood vessels grow into the tumor; whereas in tumors from VEGF/GFP-transfected ID8 cells (C and D), prominent blood vessels developing in to the tumor from nearby regular tissue are observed. Tumor from GFP-transfected ID8 cells under light microscope (E) and fluorescence stereomicroscope (F). A large central necrosis region is observed. Note the absence of prominent vessels in comparison with (D). Places of necrosis were absent in tumors from VEGF/GFP-transfected ID8 cells. G and H: Within the intraperitoneal tumor model, BRD4 Inhibitor Formulation microscopic tumor nodules are detected on the spleen by stereomicroscopy. GFP expression enables for precise detection of tumors. I: Real-time PCR revealed the presence of GFP gene, the genomic tumor marker, in many regular tissues of mice bearing VEGF164/GFP flank tumors, whereas in manage mice, GFP was only detected inside the lung.expression (Figure 3, G and H). To test the use of GFP in detecting extraperitoneal metastasis, mice had been sacrificed 10 weeks after inoculation of flank tumors and the presence of metastatic tumor in the lungs was examined by fluorescent stereo microscopy. Tumor metastasis to lungs was observed in one of seven mice in the VEGF164/GFP group, but in no mice inside the GFP group. To detect micros.
